Baidu
map

梅斯医学祝全体会员虎年(2022年)除夕快乐,阖家幸福!虎年吉祥,虎虎生威!

2022-01-30 MedSci原创 MedSci原创

梅斯医学祝全体会员新年快乐,阖家幸福!虎年吉祥,虎虎生威!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1277321, encodeId=623112e7321e3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Feb 01 07:20:53 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189461, encodeId=91a01189461d9, content=好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad36488828, createdName=ms6000000670728241, createdTime=Mon Jan 31 15:59:09 CST 2022, time=2022-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189424, encodeId=cef211894245c, content=好棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc55618600, createdName=ms6000000851325039, createdTime=Mon Jan 31 09:31:36 CST 2022, time=2022-01-31, status=1, ipAttribution=)]
    2022-02-01 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1277321, encodeId=623112e7321e3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Feb 01 07:20:53 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189461, encodeId=91a01189461d9, content=好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad36488828, createdName=ms6000000670728241, createdTime=Mon Jan 31 15:59:09 CST 2022, time=2022-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189424, encodeId=cef211894245c, content=好棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc55618600, createdName=ms6000000851325039, createdTime=Mon Jan 31 09:31:36 CST 2022, time=2022-01-31, status=1, ipAttribution=)]
    2022-01-31 ms6000000670728241

    好棒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1277321, encodeId=623112e7321e3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Feb 01 07:20:53 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189461, encodeId=91a01189461d9, content=好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad36488828, createdName=ms6000000670728241, createdTime=Mon Jan 31 15:59:09 CST 2022, time=2022-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189424, encodeId=cef211894245c, content=好棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dc55618600, createdName=ms6000000851325039, createdTime=Mon Jan 31 09:31:36 CST 2022, time=2022-01-31, status=1, ipAttribution=)]
    2022-01-31 ms6000000851325039

    好棒!

    0

相关资讯

数字化变革加速提升产业动能 维昇药业与梅斯医学达成战略协议

12月23日,专注于内分泌领域创新药物的生物医药企业维昇药业与国内知名的专业医学平台梅斯医学正式签署战略协议,双方将合力资源与能力优势,在内分泌及罕见病领域开展全面、深度地合作,包括内分泌学术平台建设

梅斯医学网站再升级,欢迎大家吐槽

梅斯医学从去年上半年改版以后,整个网站用户访问获得巨大的增加。为了进一步优化用户的访问,最近针对APP和PC端都进行了较大的改版,突出以学科为中心的原则。

梅斯医学与西安杨森爱可泰隆签署战略合作,共同推动罕见病领域认知与诊疗水平

梅斯医学与强生旗下杨森医药公司爱可泰隆签署了双方深度学术战略合作协议。双方宣布在满足各自战略发展理念的前提下,缔结战略合作关系,共同探索商业发展新模式,推动中国罕见病领域的疾病认知水平和诊疗水平

梅斯医学荣获2021中国数字医疗企业百强榜医药数字化企业TOP10

梅斯医学荣获2021中国数字医疗企业百强榜医药数字化企业TOP10

梅斯医学祝大家2022年元旦快乐,健康幸福,事业顺利 !

在2022年到来之际,梅斯医学恭祝大家2022年元旦快乐!告别2021年,在2022年每个人都能“虎”虎生威,身体健康!家庭幸福!工作顺利,事业蒸蒸日上!

梅斯医学精品课上线,打造临床精品课程

梅斯医学精品课上线,打造临床精品课程

Baidu
map
Baidu
map
Baidu
map